We caught up with senior professor of entrepreneurship at Europe’s leading business school ahead of the Future Food & Ag leadership program at INSEAD to discuss the key attributes of a food and agriculture leader.
Beyond Meat CEO Ethan Brown says he is confident of returning to growth and achieving cashflow positive status in the second half of this year, after posting a 17.7% decline in net revenues to $195.5m in the first quarter of 2023.
Beyond Meat CEO Ethan Brown faced a grilling from analysts Thursday evening as the plant-based meat firm posted a 20.6% decrease in net revenues to $79.9 million in Q4, 2022 vs Q4, 2021, with a net loss of $66.9 million.
New accounting standards that take sustainability and climate impacts into account as well as financial metrics will create a new playing field for companies, according to Emmanuel Faber, former CEO of Danone and partner at Astanor Ventures.
Zymergen will be acquired by fellow cell manufacturing company Ginkgo Bioworks for $300m, a sharp fall from Zymergen’s once $3 billion valuation.
VanEck launched its Future of Food ETF at the end of last year. AFN checks in with portfolio manager Shawn Reynolds to find out more.
Since the start of the year six agtech SPAC deals have been announced – most involving indoor farming or biotech, and all valued at over $1 billion.
The Newark-based company is set to merge with Spring Valley Acquisition Corp, raising as much as $357 million in gross proceeds at a $1.2 billion valuation.
SPACs are all the rage these days, and in agtech, we saw our first high profile SPAC earlier this year when AppHarvest listed on the NASDAQ at a $1 billion valuation.
Patrick Morris, CEO of the Vancouver-based foodtech fund, tells AFN why it decided to go down the IPO route – and what it has planned for the future.
Ahead of AgTech Week in Argentina next week, Bernardo Milesy sat down with Federico Trucco, CEO of the country’s most successful agtech startup Bioceres to find out more about the company’s recent New York Stock exchange listing.
Bioceres, the Argentinian ag biotech business, is set to list on the New York Stock Exchange (NYSE) early next year through a reverse listing with a company controlled by Uruguyuan presidential hopeful Juan Sartori.
A new food index has labeled 36 meat and fish suppliers as “high risk” for public market investors because they fail to manage critical business risks such as greenhouse gas emissions and antibiotics risk.
The raise will support late stage development for several chemical crop enhancement products in the company’s R&D pipeline.
The high-cost of customer acquisition and a recent uptick in losses for the five-year-old food tech company could make the decision to list look precarious and spell bad news for competitors also considering listing.
Smoke & mirrors, not worth the extra cost: 50 US farmers speak out on carbon markets